Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

BIOSTEM

Financiado

Cerrado

The development of biologically active metal implants for improved osseointegrat...

The development of biologically active metal implants for improved osseointegration "Osteoarthritis (OA) is the most common musculoskeletal disorder and affects approximately 355 million people world-wide. At present, no definitive cure exists for OA. Current treatment involves total joint replacement (TJR) which... ver más

18/09/2014

OLLSCOIL NA GAILLI...

205K€

Presupuesto del proyecto: 205K€

Líder del proyecto

UNIVERSITY OF GALWAY No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2014-09-18 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

OLLSCOIL NA GAILLIMHE

0.00€ | Lider

Proyectos interesantes

MAT2011-23339

Medical Technol...

Materials Scien...

130K€ Cerrado

EDiMplant

Medical Technol...

Materials Scien...

225K€ Cerrado

RTI2018-097810-B-I00

Medical Technol...

Materials Scien...

115K€ Cerrado

MAT2015-67750-C3-2-R

Medical Technol...

Materials Scien...

24K€ Cerrado

HYPORTH

Medical Technol...

Materials Scien...

7M€ Cerrado

MAT2014-52905-REDT

Medical Technol...

Materials Scien...

10K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

UNIVERSITY OF GALWAY No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 205K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto "Osteoarthritis (OA) is the most common musculoskeletal disorder and affects approximately 355 million people world-wide. At present, no definitive cure exists for OA. Current treatment involves total joint replacement (TJR) which accounts for approximately 35% of arthritis related procedures. Presently more than 200,000 total knee replacements and 70,000 total hip replacements procedure are performed annually in the UK. One of the key aspects contributing to successful fixation is the rapid and complete integration of the device with bone (osseointegration). Without this biological reaction, stability is compromised potentially resulting in aseptic loosening which generally requires revision surgery. This can be detrimental for OA patients as the quality of bone is compromised, therefore, the potential for adequate implant stabilisation is substantially reduced. Several studies have identified the surface properties of an implant as being a major determinant of osseointegration. The addition of coatings have attracted interest, however, a major stumbling block for reliable application of coating technologies is potential failure during long-term implantation. Recent data suggests that impaired peri-implant osseointegration is associated with declined osteoprogenitor recruitment. The scientific objective of this project is to identify a strategy for enhancing rapid osseointegration of implant devices through 1) increased recruitment and attachment and 2) modulation of mesenchymal stem cell (MSC) differentiation. To this end, we aim to develop specific cell targeting antibodies for optimal MSC recruitment and modulation of MSC differentiation for improved osteogenesis. If successful this project would achieve in providing a clinically feasible strategy for improving TJR which would directly impact several million patients annually."

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores